LifeStance (LFST) Q2 Revenue Jumps 11%
LifeStance Health Group (NASDAQ:LFST), a large U.S. outpatient mental healthcare provider, reported its financial results for the second quarter of fiscal 2025 on August 7, 2025. The most notable news was that revenue (GAAP) reached $345.3 million, slightly exceeding analyst expectations and registering 11% GAAP growth over the prior year. Net loss (GAAP) improved considerably to $(3.8 million), while Adjusted EBITDA rose 19%. Management raised its expectations for full-year Center Margin to $441 million to $465 million and Adjusted EBITDA to $140 million to $150 million for FY2025, building on operating gains and productivity progress. Overall, the quarter showed progress in volume, clinician expansion, and operating leverage.
Source: Analyst estimates provided by FactSet. Management expectations based on management's guidance, as provided in Q1 2025 earnings report.
LifeStance is one of the nation's largest outpatient providers of mental health care services, reaching patients in 33 states with more than 7,700 employed clinicians as of Q2 2025. Its platform includes psychologists, psychiatrists, nurse practitioners, and licensed therapists. The company delivers care through both physical centers and a robust virtual infrastructure, making it accessible to millions needing therapy, medication management, and specialty interventions.
Source Fool.com
